Rise in diabetes prevalence, surge in awareness of diabetes management, and advancements in diagnostic technologies are expected to drive the hemoglobin A1c testing devices market growth. Attention is now focused on the early and precise diagnosis of this disease to avoid complications.
Innovations in point-of-care testing devices offer quick and reliable results. Integration of telemedicine and digital health platforms have strengthened patient monitoring and compliance. With increase in investments in R&D activities, non-invasive testing methods, and continuous glucose monitoring systems are expected to bring new revolutions and drive market progress.
Most advanced testing devices are still inaccessible in many low- and middle-income countries, and their prices are unaffordable to a large segment of society. Collaborations are expected to enable diagnostic companies and healthcare providers to launch products that are more affordable and accessible.
Long-term blood glucose assessment is represented by the HbA1c test that is useful for the management of diabetes. As the prevalence of diabetes increases globally, demand for accurate and effective HbA1c testing devices is likely to increase appreciably.
Government initiatives and funds for the management and prevention of diabetes are fueling the hemoglobin A1c testing devices market size.
Increase in investments in healthcare infrastructure, especially across emerging economies is expected to offer lucrative hemoglobin A1c testing devices market opportunities through 2024. Further, rise in adoption of home healthcare and self-monitoring devices is fostering market development.
However, regulatory hurdles or reimbursement issues may prevent market growth. Despite these difficulties, the rise in demand for effective diabetes management solutions and ever-evolving diagnostic technologies, are expected to propel the HbA1c testing devices market demand.
| Attribute | Detail |
|---|---|
| Drivers |
|
Diabetes, both Type 1 and Type 2, are highly prevalent due to increase in obesity rates and unhealthy lifestyles. The International Diabetes Federation estimated that during 2019, about 463 million adults, or 9.3% of the global population, were living with this disease.
This number is projected to increase to 700 million by 2045. One of the most important challenges for contemporary medicine is to provide proper surveillance for the disease for which HbA1c testing is extremely crucial.
HbA1c tests display an average look of blood glucose levels over a long period-around two to three months. This is critical information for both the patient and the healthcare provider to make informed decisions on treatment plans.
Regular testing of HbA1c enables assessment to decide on the effectiveness of the methods to manage diabetes, and helps in reducing complicated health problems due to diabetes, such as heart diseases, neuropathy, and retinopathy.
The surge in incidence of diabetes calls for commensurate demand for HbA1c testing devices-an instrument needed in the care of people living with diabetes.
Governments and healthcare organizations have increasingly come to understand the applicability of diabetes screening programs for early diagnoses and periodic health check-ups, which in turn promotes patient awareness and availability of such testing.
This rise in awareness regarding diabetes management and prevention boosts demand for HbA1c testing devices, thereby driving the hemoglobin A1c testing devices industry growth.
Technological advancements, continuous innovation in HbA1c testing devices, and improvement in next-generation diagnostics technologies have led to more accurate, efficient, and user-friendly HbA1c testing device. These improvements not only streamline the testing process but also make it more user-friendly and convenient for patients as well as healthcare professionals.
The most important development is the formulation of point-of-care tools that can help monitor the level of HbA1c in clinics, hospitals, or even at home. POC devices yield instant results, which enable timely decision-making and avoid follow-ups.
Advances in biosensor technology, microfluidics, and lab-on-a-chip systems have enhanced the precision and reliability of HbA1c tests. These innovations opened up the route for the development of compact, portable devices, providing accurate results using minimal volumes of a sample.
Integration with digital health platforms and EHRs add utility by enabling seamless data sharing and stand as a catalyst for integrated diabetes management.
Surge in investments in research and development activities by key market players continue to galvanize a flurry of innovation. Companies develop advanced HbA1c testing devices with features of automated data analysis, connectivity with mobile applications, and increasing patient compliance in this space.
These further enhance accuracy and efficiency in monitoring diabetes while also expanding the addressable market size into a wide spectrum of healthcare settings.
The hemoglobin A1c testing devices market segmentation based on technology includes cation-exchange chromatography, immunoassay, boronate affinity chromatography, and others (enzymatic assay, etc.). The market was dominated by the immunoassay segment in 2023.
HbA1c tests form a critical part of diabetes management and diagnosis, as they can project the overall view of a patient's blood sugar average over a period of two to three months. Immunoassay-based HbA1c testing devices are becoming prominent due to their accuracy, efficiency, and user-friendly nature.
Immunoassays are tests that involve antibodies in detecting and quantifying certain proteins or molecules, in this case, HbA1c. This method offers improved benefits compared to other approaches in terms of high sensitivity, specificity, and the capacity to examine large numbers of samples at one time.
It makes immunoassay-based devices of particular interest not only to laboratories in a clinical setting but also to point-of-care settings where speed and reliability are paramount.
As per the hemoglobin A1c testing devices industry report, based on modality, the market was dominated by the automated segment in 2023. Automated testing devices have been designed to meet the most pressing needs in terms of efficiency and precision in diabetes treatment.
Such systems reduce mistakes related to the human factor and provide reproducibility of results. This reliability is also critical in the case of a chronic disease such as diabetes, for it requires correct monitoring of HbA1c levels. Given the rise in cases of diabetes all over the world, testing is now done more frequently and on a larger scale.
Automatic testing devices can easily manage large volumes with swiftness in results. This scalability comes in handy in big hospitals and diagnostic laboratories where there are continuous requirements related to quick and accurate testing.
Most modern systems are interfaced with electronic health record systems and other digital health platforms, which makes it easy to manage data or analyze it. This promotes better patient management since healthcare professionals can get patients' data in real-time, enabling timely interventions and personalized treatment plans.
Even users with limited technical knowledge can manage automated testing devices due to their user-friendly nature. This reduces the training burden on healthcare staff and enables resources to be better utilized.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the hemoglobin A1c testing devices market analysis, North America held dominant share in 2023. Advanced healthcare infrastructure and high prevalence of diabetes are driving market dynamics in the region.
Furthermore, access to hemoglobin A1c testing devices across North America, particularly in the United States, can easily be provided due to the presence of well-established networks of all types of healthcare facilities including hospitals, clinics, and diagnostic centers.
The United States has a high population of diabetes cases, with the Centers for Disease Control and Prevention estimating that around 37.3 million US citizens suffered from diabetes in 2023. This presents a high case load that requires frequent monitoring of blood sugar levels and thus creates a huge demand for hemoglobin A1c testing devices.
Additionally, growth in awareness among people about the importance of diabetes management and early diagnosis has further fortified the hemoglobin A1c testing devices market share of North America.
The United States has some of the biggest companies in this space, including Abbott Laboratories, Bio-Rad Laboratories, and Siemens Healthineers. It is continually investing in research and development to release the newest and most advanced hemoglobin A1c testing devices for managing diabetes.
The hemoglobin A1c testing devices industry is fragmented with the presence of a number of players. Emerging players in the hemoglobin A1c testing devices market include Alere Technologies AS (Abbott), GC Medical Science Corp., Osang Healthcare Co., Ltd., EKF Diagnostics Holdings, Boditech Med Inc., Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Eurolyser Diagnostica GmbH, Bayer AG, and Siemens Healthineers AG.
Key players have been have been profiled in the hemoglobin A1c testing devices market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 1.4 Bn |
| Forecast Value in 2034 | More than US$ 3.3 Bn |
| CAGR | 7.7% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.4 Bn in 2023
It is projected to grow at a CAGR of 7.7% from 2024 to 2034
In terms of technology, the immunoassay segment accounted for prominent share in 2023
North America is anticipated to account for leading share during the forecast period
Alere Technologies AS (Abbott), GC Medical Science Corp., Osang Healthcare Co., Ltd., EKF Diagnostics Holdings, Boditech Med Inc., Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Eurolyser Diagnostica GmbH, Bayer AG, and Siemens Healthineers AG.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemoglobin A1c Testing Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. PESTEL Analysis
5.2. Regulatory Scenario by Region/Country
5.3. PORTER’s Five Forces Analysis
5.4. Product/Brand Analysis of Haemoglobin A1c Testing Devices
5.5. Technological Advancement
5.6. Incidence and Prevalence Rate of Diabetes
6. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2020-2034
6.3.1. Cation-exchange Chromatography
6.3.2. Immunoassay
6.3.3. Boronate Affinity Chromatography
6.3.4. Others (Enzymatic assay, etc.)
6.4. Market Attractiveness Analysis, by Technology
7. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Modality
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Modality, 2020-2034
7.3.1. Automated
7.3.2. Semi-automated
7.4. Market Attractiveness Analysis, by Modality
8. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Ambulatory Surgical Centres
8.3.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Hemoglobin A1c Testing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technology, 2020-2034
10.2.1. Cation-exchange Chromatography
10.2.2. Immunoassay
10.2.3. Boronate Affinity Chromatography
10.2.4. Others (Enzymatic assay, etc.)
10.3. Market Value Forecast, by Modality, 2020-2034
10.3.1. Automated
10.3.2. Semi-automated
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Ambulatory Surgical Centres
10.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
10.5. Market Value Forecast, by Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Modality
10.6.3. By End-user
10.6.4. By Country
11. Europe Hemoglobin A1c Testing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2020-2034
11.2.1. Cation-exchange Chromatography
11.2.2. Immunoassay
11.2.3. Boronate Affinity Chromatography
11.2.4. Others (Enzymatic assay, etc.)
11.3. Market Value Forecast, by Modality, 2020-2034
11.3.1. Automated
11.3.2. Semi-automated
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Ambulatory Surgical Centres
11.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Modality
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Hemoglobin A1c Testing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2020-2034
12.2.1. Cation-exchange Chromatography
12.2.2. Immunoassay
12.2.3. Boronate Affinity Chromatography
12.2.4. Others (Enzymatic assay, etc.)
12.3. Market Value Forecast, by Modality, 2020-2034
12.3.1. Automated
12.3.2. Semi-automated
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Ambulatory Surgical Centres
12.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Modality
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Hemoglobin A1c Testing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2020-2034
13.2.1. Cation-exchange Chromatography
13.2.2. Immunoassay
13.2.3. Boronate Affinity Chromatography
13.2.4. Others (Enzymatic assay, etc.)
13.3. Market Value Forecast, by Modality, 2020-2034
13.3.1. Automated
13.3.2. Semi-automated
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Ambulatory Surgical Centres
13.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Modality
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Hemoglobin A1c Testing Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2020-2034
14.2.1. Cation-exchange Chromatography
14.2.2. Immunoassay
14.2.3. Boronate Affinity Chromatography
14.2.4. Others (Enzymatic assay, etc.)
14.3. Market Value Forecast, by Modality, 2020-2034
14.3.1. Automated
14.3.2. Semi-automated
14.4. Market Value Forecast, by End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Ambulatory Surgical Centres
14.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technology
14.6.2. By Modality
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Alere Technologies AS (Abbott)
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. GC Medical Science Corp.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Osang Healthcare Co., Ltd
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. EKF Diagnostics Holdings
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Boditech Med Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Eurolyser Diagnostica GmbH
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Bayer AG
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Siemens Healthineers
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Other Prominent Players
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 02: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2020-2034
Table 03: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 07: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2020-2034
Table 08: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 11: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2020-2034
Table 12: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 15: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2020-2034
Table 16: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 19: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2020-2034
Table 20: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2020-2034
Table 23: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2020-2034
Table 24: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, 2020-2034
Figure 02: Global Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2023
Figure 03: Global Hemoglobin A1c Testing Devices Market Value Share, by Modality, 2023
Figure 04: Global Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2023
Figure 05: Global Hemoglobin A1c Testing Devices Market Value Share, by Region, 2023
Figure 06: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 07: Global Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2023
Figure 08: Global Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2034
Figure 09: Global Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Technology, 2024-2034
Figure 10: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Cation-exchange chromatography, 2020‒2034
Figure 11: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Cation-exchange chromatography, 2023 and 2034
Figure 12: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Immunoassay, 2020‒2034
Figure 13: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Immunoassay, 2023 and 2034
Figure 14: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Boronate affinity chromatography, 2020‒2034
Figure 15: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Boronate affinity chromatography, 2023 and 2034
Figure 16: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Others (Enzymatic assay, etc.) 2020‒2034
Figure 17: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Others (Enzymatic assay, etc.), 2023 and 2034
Figure 18: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Modality, 2023 and 2034
Figure 19: Global Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2023
Figure 20: Global Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2034
Figure 21: Global Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Modality, 2024-2034
Figure 22: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Automated, 2020‒2034
Figure 23: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Automated, 2023 and 2034
Figure 24: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Semi-Automated, 2020‒2034
Figure 25: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Semi-Automated, 2023 and 2034
Figure 26: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 27: Global Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2023
Figure 28: Global Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2034
Figure 29: Global Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 30: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Hospitals, 2020‒2034
Figure 31: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Hospitals, 2023 and 2034
Figure 32: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Diagnostic Laboratories, 2020‒2034
Figure 33: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Diagnostic Laboratories, 2023 and 2034
Figure 34: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Ambulatory Surgical Centres, 2020‒2034
Figure 35: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Ambulatory Surgical Centres, 2023 and 2034
Figure 36: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), by Others (Speciality Clinics, Academics & Research Institutes, etc.), 2020‒2034
Figure 37: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Others (Speciality Clinics, Academics & Research Institutes, etc.), 2023 and 2034
Figure 38: Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Region, 2023 and 2034
Figure 39: Global Hemoglobin A1c Testing Devices Market Share Analysis, by Region, 2023
Figure 40: Global Hemoglobin A1c Testing Devices Market Share Analysis, by Region, 2034
Figure 41: Global Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Region, 2023-2034
Figure 42: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 43: North America Hemoglobin A1c Testing Devices Market Value Share Analysis, by Country, 2023 and 2034
Figure 44: North America Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Country, 2024-2034
Figure 45: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 46: North America Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2023
Figure 47: North America Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2034
Figure 48: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Modality, 2023 and 2034
Figure 49: North America Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2023
Figure 50: North America Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2034
Figure 51: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 52: North America Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2023
Figure 53: North America Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2034
Figure 54: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 55: Europe Hemoglobin A1c Testing Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 56: Europe Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 57: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 58: Europe Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2023
Figure 59: Europe Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2034
Figure 60: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Modality, 2023 and 2034
Figure 61: Europe Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2023
Figure 62: Europe Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2034
Figure 63: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 64: Europe Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2023
Figure 65: Europe Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2034
Figure 66: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 67: Asia Pacific Hemoglobin A1c Testing Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 68: Asia Pacific Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 69: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 70: Asia Pacific Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2023
Figure 71: Asia Pacific Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2034
Figure 72: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Modality, 2023 and 2034
Figure 73: Asia Pacific Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2023
Figure 74: Asia Pacific Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2034
Figure 75: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 76: Asia Pacific Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2023
Figure 77: Asia Pacific Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2034
Figure 78: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 79: Latin America Hemoglobin A1c Testing Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 80: Latin America Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 81: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 82: Latin America Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2023
Figure 83: Latin America Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2034
Figure 84: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Modality, 2023 and 2034
Figure 85: Latin America Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2023
Figure 86: Latin America Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2034
Figure 87: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 88: Latin America Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2023
Figure 89: Latin America Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2034
Figure 90: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 91: Middle East & Africa Hemoglobin A1c Testing Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 92: Middle East & Africa Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 93: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
Figure 94: Middle East & Africa Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2023
Figure 95: Middle East & Africa Hemoglobin A1c Testing Devices Market Share Analysis, by Technology, 2034
Figure 96: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by Modality, 2023 and 2034
Figure 97: Middle East & Africa Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2023
Figure 98: Middle East & Africa Hemoglobin A1c Testing Devices Market Share Analysis, by Modality, 2034
Figure 99: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 100: Middle East & Africa Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2023
Figure 101: Middle East & Africa Hemoglobin A1c Testing Devices Market Share Analysis, by End-user, 2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hemoglobin A1c Testing Devices Market
